Linnaeus Therapeutics

Drug Discovery · Haddonfield, NJ · Founded 2016 · Privately Held (backing)

Developer of molecular therapeutics designed to treat cancer and skin pigmentation disorders. Linnaeus Therapeutics is based in Haddonfield, NJ and was founded in 2016. It was valued at $83.1 million at its later-stage round in Apr 2026, the last priced event on record. It has raised $35.6 million across 8 recorded rounds; the latest was a $5 million seed round in Feb 2026.

PMV mark · valuation
$83.1M
Oct 2026
Priced at
its later-stage round
Apr 2026
Total raised
$35.6M
Last round
Seed Round
Feb 2026
How much has Linnaeus Therapeutics raised?
$35.6Macross 8 recorded rounds · Aug 2021 – Feb 2026

Most recently, Linnaeus Therapeutics raised $5.0M in its Seed Round (Feb 2026).

Free account
More of Linnaeus Therapeutics with a free account
  • ·Watch Linnaeus Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Linnaeus Therapeutics round by round

8 rounds
Feb 2026Seed Round$5.0MSEC filing▮
26 investors participated
Aug 2025Debt$1.3MSEC filing▮
3 investors participated
Aug 2024Early Stage VC$5.8MSEC filing▮
12 investors participated
Jan 2023Seed Round$3.1MSEC filing▮
8 investors participated
Jan 2023Accelerator/Incubatorundisclosed▮
+ 1 more investors · free account
Aug 2021Seed Round$4.3MSEC filing▮
15 investors participated
+ 2 earlier rounds · a free account shows the full history

How much has Linnaeus Therapeutics raised?

Linnaeus Therapeutics has raised $35.6 million across 8 recorded rounds since 2018. The largest was a $5.8 million early-stage round in Aug 2024; the most recent was a $5 million seed round in Feb 2026.

Linnaeus Therapeutics has filed 9 Form Ds with the SEC since 2018, most recently in Mar 2026 ($4.8 million sold to 25 investors).

Linnaeus Therapeutics investors

8 investors are on record for Linnaeus Therapeutics, including Springboard Enterprises, Kairos Ventures, National Cancer Institute and National Institute for Allergy and Infectious Disease. The seed round in Feb 2026 drew 26 investors.

For fundraisers
Raising for a company like Linnaeus Therapeutics?

8 investors have backed Linnaeus Therapeutics — start your target list with the firms already writing checks in drug discovery.

See all 8 investors →

Frequently asked about Linnaeus Therapeutics

How much has Linnaeus Therapeutics raised?
Linnaeus Therapeutics has raised $35.6M in total across 8 recorded funding rounds.
When was Linnaeus Therapeutics's last funding round?
Linnaeus Therapeutics's most recent recorded round was Seed Round in Feb 2026, raising $5.0M.